Biotech 2050 Podcast

132. Targeting ferroptosis cell death for cancer and beyond, Luba Greenwood, CEO, Kojin Therapeutics


Listen Later

Synopsis:
Luba Greenwood is the CEO of Kojin Therapeutics and Managing Partner of Dana Farber Cancer Institute Venture Fund. Kojin Therapeutics harnesses groundbreaking discoveries in cell state and ferroptosis biology to create novel therapies and cures for diseases traditionally considered intractable. The Dana Farber Cancer Institute Venture Fund accelerates the development of new research and technologies to treat incurable diseases, particularly in oncology and immunology. Luba discusses the early years of her career as a lawyer and how her legal experience relates to running a biotech company, her background in big pharma at Pfizer and Roche, and the work Kojin is doing in novel biology. She also dives into the qualities that she values in a board member, the importance of company culture, and her perspective on what good leadership looks like.
Biography:
Luba Greenwood is a leading figure in the biotech and digital health world with vast experience as an executive, investor, and company builder in the biotech, life sciences, diagnostics, and tech sectors. Luba is the Chief Executive Officer of Kojin Therapeutics, a world leader in ferroptosis, pioneering breakthrough medicines in oncology, immunology, neuro, metabolism, and inflammation. Most recently, Luba has served as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital, which she has built and launched. She has also taught at Harvard University at the School of Engineering and Applied Sciences.
Previously, Ms. Greenwood served in leadership roles at Google Life Sciences, Verily, and was a VP Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Ms. Greenwood has led $5B+ in deals and investments across multiple therapeutic areas and life sciences globally. She has also co-founded companies in the oncology, AI/ML, women’s health and microbiome space.
Luba began her career as a lawyer, practicing at Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology.
...more
View all episodesView all episodes
Download on the App Store

Biotech 2050 PodcastBy Biotech 2050

  • 4.7
  • 4.7
  • 4.7
  • 4.7
  • 4.7

4.7

59 ratings


More shows like Biotech 2050 Podcast

View all
WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,716 Listeners

Exchanges by Goldman Sachs

Exchanges

981 Listeners

The Knowledge Project with Shane Parrish by Shane Parrish

The Knowledge Project with Shane Parrish

2,668 Listeners

Odd Lots by Bloomberg

Odd Lots

1,867 Listeners

Masters of Scale by WaitWhat

Masters of Scale

3,987 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

The Intrinsic Value Podcast - The Investor’s Podcast Network by The Investor's Podcast Network

The Intrinsic Value Podcast - The Investor’s Podcast Network

558 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

86 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

144 Listeners

Business Breakdowns by Colossus | Investing & Business Podcasts

Business Breakdowns

345 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

The So What from BCG by Boston Consulting Group BCG

The So What from BCG

221 Listeners

HBR On Leadership by Harvard Business Review

HBR On Leadership

161 Listeners